Boston Scientific (BSX) Accounts Payables (2009 - 2026)

Boston Scientific has disclosed Accounts Payables across 18 years of filings, most recently posting $1.1 billion for Q1 2026.

• Accounts Payables for Q1 2026 came in at $1.1 billion, up 13.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 13.65% YoY), and the FY2025 annual result was $1.1 billion, up 19.17% from the prior year.
• Accounts Payables came in at $1.1 billion for Q1 2026 at Boston Scientific, roughly flat from $1.1 billion in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $1.1 billion in Q4 2025 to a low of $696.0 million in Q1 2022.
• The 5-year median for Accounts Payables is $921.0 million (2024), against an average of $922.2 million.
• Across the five-year window, Accounts Payables rose 24.71% in 2023 and slipped 2.37% in 2024, its largest moves.
• Boston Scientific's Accounts Payables stood at $862.0 million in 2022, then increased by 9.28% to $942.0 million in 2023, then advanced by 1.91% to $960.0 million in 2024, then increased by 19.17% to $1.1 billion in 2025, then retreated by 0.26% to $1.1 billion in 2026.
• The last three Accounts Payables figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.